The 97th volume of Bioactive Lipid Mediators in Cardiopulmonary Pharmacology provides readers with the most recent information on lipid mediator-related issues. These mediators participate in a wide range of signaling pathways that control pathological and physiological reactions. This new publication contains chapters on cyclooxygenases and vascular function, cyclooxygenases and platelet function, eicosanoids and cardiomyopathies, cytochrome P450 bioactive lipids in the heart, soluble epoxide hydrolase and leukotoxin in the heart and lung, the role of cytochrome P450-epoxygenase and soluble epoxide hydrolase in the regulation of vascular response,
Other crucial parts discuss Endocannabinoids as Bioactive Metabolites, Oxylipins and Aspirin Exacerbated Respiratory Disease, Omega-3 Oxylipids, Resolvins, Lipoxins and Inflammation, and Cytochrome P450 Eicosanoids and the Brain.
reviews written by renowned authorities on bioactive lipid mediators are provided.
emphasis on the creation of innovative treatments and current issues
includes a wide spectrum of bioactive lipids produced by the metabolism of omega-3 and omega-6 PUFAs through COX, LOX, or CYP.
